The biocompatibility of silver-containing Na2O· CaO·2SiO2 glass prepared by sol-gel method: In vitro studies

Journal of Biomedical Materials Research - Part B Applied Biomaterials

Volumn 92, Issue 1, 2010, Pages 102-110

  Raucci, Maria Grazia ^a   Adesanya, Kehinde ^b   Di Silvio, Lucy ^b   Catauro, Michelina ^c   Ambrosio, Luigi ^a  

^a CNR   (Italy)

^b KING'S COLLEGE LONDON   (United Kingdom)

^c SECOND UNIVERSITY OF NAPLES   (Italy)

Author keywords

Alamar blue; Antibacterial material; MTT assay; Silver containing gel glass; Sterilization methods

Indexed keywords

ANTIBACTERIAL MATERIAL; ANTIBACTERIAL MATERIALS; BIOLOGICAL RESPONSE; CELL VIABILITY; CYTOCOMPATIBILITY; DIRECT CONTACT; GEL GLASS; HUMAN OSTEOBLAST-LIKE CELLS; IN-VITRO; MTT ASSAYS; SOL-GEL METHODS;

BIOCOMPATIBILITY; BIOLOGICAL MATERIALS; CELL CULTURE; GELS; GLASS; ORGANIC POLYMERS; SILICON COMPOUNDS; SILVER; SODIUM; SOL-GELS; SOLS; STERILIZATION (CLEANING);

SOL-GEL PROCESS;

BIOMATERIAL; SILVER;

ARTICLE; AUTOCLAVE; BIOCOMPATIBILITY; CELL LINE; CELL PROLIFERATION; CELL STRUCTURE; CELL VIABILITY; GAMMA IRRADIATION; GEL; HUMAN; HUMAN CELL; IN VITRO STUDY; INSTRUMENT STERILIZATION; OSTEOBLAST;

BIOCOMPATIBLE MATERIALS; CALCIUM COMPOUNDS; CELL LINE, TUMOR; GELS; GLASS; HUMANS; MICROSCOPY, FLUORESCENCE; OXIDES; SILICON DIOXIDE; SILVER; SODIUM COMPOUNDS;

EID: 74749103987     PISSN: 15524973     EISSN: 15524981     Source Type: Journal    
DOI: 10.1002/jbm.b.31495     Document Type: Article

References (35)

1. Di Silvio L, Bonfield W. Biodegradable drug delivery system for the treatment of bone infection and repair. J Mater Sci Mater Med 1999;10:653-658.
2. Raad I, Hachem R, Zermeno A, Dumo M, Bodey GP. In vitro antimicrobial efficacy of silver iontophoretic catheter. Biomaterials 1996;17:1055-1059.
3. Jeong SH, Yeo SY, Yi SC. The effect of filler particle size on the antibacterial properties of compounded polymer/silver fibers. J Mater Sci 2005;40:5407-5411.
4. 2 supported silver/zinc-silver materials. Dent Mater 2008;24:244-249.
5. Lehninger AL, Nelson DL, Cox MM. Principles of Biochemistry, 2nd ed. New York: Worth; 1993.
6. Liau SY, Read DC, Pugh WJ, Furr JR, Russell AD. Interaction of silver-nitrate with readily identifiable groups relationship to the antibacterial action of silver ions. Lett Appl Microbiol 1997;25:279-283.
7. Feng QL, Wu J, Chen GQ, Cui FZ, Kim TN, Kim JO. A mechanistic study of the antibacterial effect of silver ions on E. Coli and Staphylococcus aureus. J Biomed Mater Res 2000;52:662-668.
8. Davies RI, Etris SF. Development and functions of silver in water-purification and disease control. Catal Today 1997;36:107-114.
9. Pedahzur R, Shuval HI, Ulitzur S. Silver and hydrogen peroxide as potential drinking water disinfectants their bactericidal effects and possible modes of action. Water Sci Technol 1997;35:87-93.
10. 2/PCL hybrid materials synthesized by sol-gel processing. J Biomed Mater Res Part A 2006;77:340-350.
11. Catauro M, Raucci MG, Continenza MA, Marotta A. Biocompatibility tests with fibroblasts of CaO rich calcium silicate glasses. J Mater Sci 2004;39:373-375.
12. 2. J Mater Sci Mater Med 2004;15:991-995.
13. Kirkpatrick CJ, Dekker A. Quantitative evaluation of cell interaction with biomaterials in vitro. Adv Biomater 1992;10:31-41.
14. Kirkpatrick CJ. A critical view of current and proposed methodologies for biocompatibility testing: cytotoxicity in vitro. Regul Aff 1992;4:13-32.
15. Dekker A, Panfil C, Valdor M, Pennartz G, Richter H, Mittermayer CH, Kirkpatrick CJ. Quantitative methods for in vitro cytotoxicity testing of biomaterials. Cell Mater 1994;4: 101-112.
16. Abe K, Matsuki N. Measurement of cellular 3-(4,5-dimethylthiazol-2-yl)-2, 5 diphenyltetrazolium bromide (MTT) reduction activity and lactate dehydrogenase release using MTT. Neurosci Res 2000;38:325-329.
17. O'brien J, Wilson I, Orton T, Pognan F. Investigation of the alamar blue (resazurin) fluorescent dye for the assessment of mammalian cell toxicity. Eur J Biochem 2000;267:5421-5426.
18. Hamid R, Rotshteyn Y, Rabadi L, Parikh R, Bullock P. Comparison of alamar blue and MTT assays for high through-put screening. Toxicol Vitro 2004;18:703-710.
19. 2 glass prepared by sol-gel method. J Mater Sci Mater Med 2004;15:831-837.
20. Essodaigui M, Broxterman HJ, Garnier-Suillerot A. Kinetic analysis of calcein and calcein-acetoxymethylester efflux mediated by the multidrug resistance protein and P-glycoprotein. Biochemistry 1998;37:2243-2250.
21. Bischof JC, Padanilam J, Holmes WH, Ezzell RM, Lee RC, Tompkins RG, Yarmush ML, Toner M. Dynamics of cell membrane permeability changes at supraphysiological temperatures. J Biophys 1995;68:2608-2614.
22. Rye HS, Glazer AN. Interaction of dimeric intercalating dyes with single-stranded DNA. Nucleic Acids Res 1995;23:1215-1222.
23. Gonzalez RJ, Tarloff JB. Evaluation of hepatic subcellular fractions for alamar blue and MTT reductase activity. Toxicol Vitro 2001;15:257-259.
24. Gottenbos B, Busscher HJ, Van Der Mei HC, Nieuwenhuis P. Pathogenesis and prevention of biomaterial centered infections. J Mater Sci 2002;13:717-722.
25. Stoodley P, Sauer K, Davies DG, Costerton JW. Biofilms as complex differentiated communities. Annu Rev Microbiol 2002;56:187-209.
26. Fux CA, Costerton JW, Stewart PS, Stoodley P. Survival strategies of infectious biofilms. Trends Microbiol 2005;13:34-40.
27. Hall-Stoodley L, Costerton JW, Stoodley P. Bacterial biofilms: from the natural environment to infectious diseases. Nat Rev Microbiol 2004;2:95-108.
28. Turkoski B. Fighting infection. An ongoing challenge. II. Antibacterials. Orthop Nurs 2005;24:210-221.
29. Gristina AG. Biomaterial-centered infection: Microbial adhesion versus tissue integration. Science 1987;237:1588-1595.
30. Bechert T, Böswald M, Lugauer S, Regenfus A, Greil J, Guggenbichler J-P. The Erlanger silver catheter: In vitro results for antimicrobial activity. Infection 1999;27:24-29.
31. Bosetti M, Masseè A, Tobin E, Cannas M. Silver coated materials for external fixation devices: In vitro biocompatibility and genotoxicity. Biomaterials 2002;23:887-892.
32. Mehta S, Humphrey JS, Dchenkmann DI, Seaber AV, Vail TP. Gentamicin distribution from collagen carrier. J Orthop Res 1996;14:749-754.
33. Bromberg LE, Buxton DK, Friden PM. Novel periodontal drug delivery system for treatment of periodontitis. J Control Release 2001;71:251-259.
34. Zhang W, Torabinejad M, Li Y. Evaluation of cytotoxicity of MTAD using the MTT-tetrazolium method. J Endod 2003;29:654-657.
35. Gazzano-Santoro H, Ralph P, Ryskamp TC, Chen AB, Mukku VR. A non-radioactive complement-dependent cytotoxicity assay for anti-CD20 monoclonal antibody. J Immunol Methods 1997;28:163-171.